These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5364727)

  • 1. Relationships between headache and amine changes after administration of reserpine to migrainous patients.
    Curzon G; Barrie M; Wilkinson MI
    J Neurol Neurosurg Psychiatry; 1969 Dec; 32(6):555-61. PubMed ID: 5364727
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of reserpine injections in migrainous and normal control subjects, with estimations of urinary 5-hydroxyindoleacetic acid.
    Tandon RN; Sur BK; Nath K
    Neurology; 1969 Nov; 19(11):1073-9. PubMed ID: 5388075
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluctuation of 5-hydroxy-indole compounds in the urine of migrainous patients.
    Deanović Z; Iskrić S; Dupelj M
    Biomedicine; 1975 Nov; 23(9):346-9. PubMed ID: 1231931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tryptaminuria and serotonin and catecholamine catabolism in the course of migraine].
    Sicuteri F; Periti P; Anselmi B; Fanciullacci M
    Boll Soc Ital Biol Sper; 1965 May; 41(9):474-5. PubMed ID: 5876770
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of reserpine on catecholamine metabolism and behavior in retarded children.
    Anton AH
    Clin Pharmacol Ther; 1966; 7(6):727-39. PubMed ID: 5918009
    [No Abstract]   [Full Text] [Related]  

  • 6. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.
    Curran DA; Hinterberger H; Lance JW
    Brain; 1965 Dec; 88(5):997-1010. PubMed ID: 5325360
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin-releasing factors in migrainous patients.
    Mück-Seler D; Deanović Z; Dupelj M
    Adv Neurol; 1982; 33():257-64. PubMed ID: 6172961
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of reserpine in imipramine-resistant depressive patients. Clinical and biochemical study.
    Haskovec L; Rysánek K
    Psychopharmacologia; 1967; 11(1):18-30. PubMed ID: 4876300
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-hydroxyindoles and migraine.
    Curzon G
    Adv Pharmacol (1962); 1968; 6(Pt B):191-200. PubMed ID: 5658321
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin and migraine.
    Lance JW; Anthony M; Hinterberger H
    Trans Am Neurol Assoc; 1967; 92():128-31. PubMed ID: 5634006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary elimination of 5-hydroxyindolacetic acid (5HIAA) and 3-methoxy-4-hydroxy-mandelic acid (VMA) and test of serotonin conversion in the course of natural and surgical menopause].
    Gasparri F; Periti P; Battaglia GB
    Boll Soc Ital Biol Sper; 1966 Jul; 42(13):851-4. PubMed ID: 5967362
    [No Abstract]   [Full Text] [Related]  

  • 12. [Excretion of 5-hydroxyindoleacetic acid and vanilmandelic acid in patients with glaucoma].
    Dienstbier E; Balík J; Duchon J; Fischer O
    Cesk Oftalmol; 1967 May; 23(3):177-86. PubMed ID: 5586682
    [No Abstract]   [Full Text] [Related]  

  • 13. The histaminuria in vascular headache.
    Sjaastad O; Sjaastad OV
    Acta Neurol Scand; 1970; 46(3):331-42. PubMed ID: 5505975
    [No Abstract]   [Full Text] [Related]  

  • 14. Derangement of serotonin system in migrainous patients with analgesic abuse headache: clues from platelets.
    Srikiatkhachorn A; Maneesri S; Govitrapong P; Kasantikul V
    Headache; 1998 Jan; 38(1):43-9. PubMed ID: 9505003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urinary elimination of vanillyl mandelic acid and 5-hydroxyindoleacetic acid in healthy Puerto Ricans.
    Suárez RM; Alvarado F; Suárez RM; Olavarrieta S
    Bol Asoc Med P R; 1967 May; 59(5):216-21. PubMed ID: 5232816
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation between vanilyl mandelic acid and 5-hydroxyindoleacetic acid excretion in a patient with a carcinoid tumour.
    Marshall PB
    J Pharm Pharmacol; 1966 Nov; 18(11):764-5. PubMed ID: 4382061
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary elimination of 5-hydroxy-indolacetic acid (5HIAA) and 3-methoxy-4-hydroxy-mandelic acid (VMA) during spontaneous and surgical menopause in relation to the incidence of vasomotor disorders].
    Gasparri F; Periti P; Lo Stumbo F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):951-3. PubMed ID: 5969312
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of the biogenic amines during therapy with imipramine].
    Bruno A; Cumer Bruno S
    Riv Neurobiol; 1968; 14(4):555-63. PubMed ID: 5738407
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the cigarette smoking hibit on urinary elimination of tryptamine, 5-hydroxy-indolacetic acid and 3-methoxy-4-hydroxy-mandelic acid in healthy young women].
    Periti P; Gasparri F; Santini D
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):954-7. PubMed ID: 5969314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.